Grant: Collaborative Health Research Projects
University of Waterloo
$71,486.00
Dynamics of multi-modal anti-angiogenic, anti-vascular, and cytotoxic therapies: Potential for significant clinical impact
EF 2009-10
Résumé
The application of physics and mathematics to medicine is one of the most rapidly growing areas of interdisciplinary research. Mathematical modeling can provide a quantitative framework to discuss, in detail, the interaction between all components of complex biological systems, as well as to test various therapeutic interventions. The combination of novel computational techniques and mathematical models, grounded in experimental and clinical data, thus provides a powerful new tool in biomedical research. The identification of major factors that influence treatment response in cancerous tumors has been a problem of long-standing interest and relevance to clinical oncology. While conventional cytotoxic treatments like radiotherapy and chemotherapy have contributed to major advancement in cancer control, there remains significant room for further improvement in many tumor sites. Novel molecularly-targeted treatments, like inhibitors of tumor angiogenesis (the formation of blood vessels from pre-existing vessels), have the potential to complement conventional treatments. There is currently minimal pre-clinical or clinical evidence on which to base decisions about how to optimally combine anti-angiogenic and cytotoxic therapies. Our working hypothesis is that mathematical modeling based on existing and novel biophysical models of the interactions between the vascular, interstitial and cellular compartments of a tumor, and the impact on these interactions on nutrient delivery to cancer cells, can guide the rationale sequencing of anti-angiogenic therapies with existing cytotoxic treatments. The project will revolve around a dynamic process of mathematical model development and refinement, using data derived from histologic and imaging studies in animals, and patient data from ongoing clinical studies in patients with cervix cancer and other tumors.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
337656-2007
Name nom
Kohandel, Mohammad
Department département
Applied Mathematics
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
71486
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
3
Nb partie
3
Application title
Dynamics of multi-modal anti-angiogenic, anti-vascular, and cytotoxic therapies: Potential for significant clinical impact
Keyword
NA
Application summary
The application of physics and mathematics to medicine is one of the most rapidly growing areas of interdisciplinary research. Mathematical modeling can provide a quantitative framework to discuss, in detail, the interaction between all components of complex biological systems, as well as to test various therapeutic interventions. The combination of novel computational techniques and mathematical models, grounded in experimental and clinical data, thus provides a powerful new tool in biomedical research. The identification of major factors that influence treatment response in cancerous tumors has been a problem of long-standing interest and relevance to clinical oncology. While conventional cytotoxic treatments like radiotherapy and chemotherapy have contributed to major advancement in cancer control, there remains significant room for further improvement in many tumor sites. Novel molecularly-targeted treatments, like inhibitors of tumor angiogenesis (the formation of blood vessels from pre-existing vessels), have the potential to complement conventional treatments. There is currently minimal pre-clinical or clinical evidence on which to base decisions about how to optimally combine anti-angiogenic and cytotoxic therapies. Our working hypothesis is that mathematical modeling based on existing and novel biophysical models of the interactions between the vascular, interstitial and cellular compartments of a tumor, and the impact on these interactions on nutrient delivery to cancer cells, can guide the rationale sequencing of anti-angiogenic therapies with existing cytotoxic treatments. The project will revolve around a dynamic process of mathematical model development and refinement, using data derived from histologic and imaging studies in animals, and patient data from ongoing clinical studies in patients with cervix cancer and other tumors.